Rentokil Initial Plc Stock Performance
| RKLIF Stock | USD 4.69 0.34 6.76% |
The company holds a Beta of 0.0917, which implies not very significant fluctuations relative to the market. As returns on the market increase, Rentokil Initial's returns are expected to increase less than the market. However, during the bear market, the loss of holding Rentokil Initial is expected to be smaller as well. At this point, Rentokil Initial plc has a negative expected return of -0.24%. Please make sure to check Rentokil Initial's skewness, as well as the relationship between the day median price and relative strength index , to decide if Rentokil Initial plc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Rentokil Initial plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's forward indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 550.8 M | |
| Total Cashflows From Investing Activities | -441.1 M |
Rentokil |
Rentokil Initial Relative Risk vs. Return Landscape
If you would invest 581.00 in Rentokil Initial plc on August 26, 2024 and sell it today you would lose (112.00) from holding Rentokil Initial plc or give up 19.28% of portfolio value over 90 days. Rentokil Initial plc is currently producing negative expected returns and takes up 4.1558% volatility of returns over 90 trading days. Put another way, 37% of traded pink sheets are less volatile than Rentokil, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Rentokil Initial Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rentokil Initial's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Rentokil Initial plc, and traders can use it to determine the average amount a Rentokil Initial's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0573
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RKLIF |
Estimated Market Risk
| 4.16 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Rentokil Initial is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rentokil Initial by adding Rentokil Initial to a well-diversified portfolio.
Rentokil Initial Fundamentals Growth
Rentokil Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Rentokil Initial, and Rentokil Initial fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Rentokil Pink Sheet performance.
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0419 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 18.1 B | |||
| Shares Outstanding | 2.52 B | |||
| Price To Earning | 38.36 X | |||
| Price To Book | 9.36 X | |||
| Price To Sales | 5.35 X | |||
| Revenue | 2.96 B | |||
| EBITDA | 656.6 M | |||
| Cash And Equivalents | 2.37 B | |||
| Cash Per Share | 1.28 X | |||
| Total Debt | 1.26 B | |||
| Debt To Equity | 2.64 % | |||
| Book Value Per Share | 0.77 X | |||
| Cash Flow From Operations | 563.2 M | |||
| Earnings Per Share | 0.17 X | |||
| Total Asset | 4.32 B | |||
| Retained Earnings | 2.07 B | |||
| Current Asset | 593 M | |||
| Current Liabilities | 789 M | |||
About Rentokil Initial Performance
By analyzing Rentokil Initial's fundamental ratios, stakeholders can gain valuable insights into Rentokil Initial's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Rentokil Initial has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Rentokil Initial has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom. Rentokil Initial operates under Specialty Business Services classification in the United States and is traded on OTC Exchange. It employs 46000 people.Things to note about Rentokil Initial plc performance evaluation
Checking the ongoing alerts about Rentokil Initial for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Rentokil Initial plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Rentokil Initial plc generated a negative expected return over the last 90 days | |
| Rentokil Initial plc has high historical volatility and very poor performance | |
| Over 76.0% of the company shares are owned by institutional investors |
- Analyzing Rentokil Initial's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Rentokil Initial's stock is overvalued or undervalued compared to its peers.
- Examining Rentokil Initial's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Rentokil Initial's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Rentokil Initial's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Rentokil Initial's pink sheet. These opinions can provide insight into Rentokil Initial's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Rentokil Pink Sheet analysis
When running Rentokil Initial's price analysis, check to measure Rentokil Initial's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rentokil Initial is operating at the current time. Most of Rentokil Initial's value examination focuses on studying past and present price action to predict the probability of Rentokil Initial's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rentokil Initial's price. Additionally, you may evaluate how the addition of Rentokil Initial to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |